What Is the Cost of Lu-177 PSMA Therapy in Germany?
The cost of lu-177 PSMA therapy in Germany typically ranges from $2,500 to $22,000 USD, depending on the hospital, city, and type of procedure.
Lutetium-177 PSMA therapy is a radioactive medicine that targets prostate cancer cells carrying the PSMA protein. It is used for metastatic prostate cancer that no longer responds to hormone therapy. In Germany, the total depends on:
- Number of treatments: up to six, 6 weeks apart.
- Scans: PSMA PET scan to check suitability.
- Radiation precautions: after each treatment.
- Blood tests: to monitor the bone marrow.
Lu-177 PSMA therapy is usually priced per cycle, and a full course may cost much more than the range above. Ask whether a quote covers one cycle or the whole course.
How Lu-177 PSMA Therapy Is Given
UCLH explains that Lu-177 PSMA therapy is used for metastatic castration-resistant prostate cancer. It is given as a drip over about 30 minutes, with up to six treatments 6 weeks apart.
After each treatment, radiation precautions include sleeping in a separate bed for 2 to 3 days, keeping a distance from children for 7 days and from pregnant partners for 15 days.
Our Services for Lu177-PSMA Therapy in Germany
Transparent, professional support—without the hassles.
Book Doctor Appointment
Choose a specialist and schedule a convenient consultation.
Video or In-person Consultation
Consult remotely or meet your doctor directly at the hospital.
Compare Cost Estimates
Review transparent estimates from suitable hospitals.
Hospitalisation Support
Get coordinated assistance throughout your hospital stay.
Side Effects of Lu-177 PSMA Therapy
Dry mouth, tiredness and feeling sick are common.
The bone marrow can be suppressed in 1 to 10 in 100 people, so regular blood tests are needed.
Radionuclide Therapy in Germany
International patients are usually treated in Germany as self-paying patients: the hospital reviews the medical reports, sends a cost estimate and asks for an advance payment before admission, then settles the final bill after discharge.
Inpatient hospital care in Germany is billed under the German DRG system, which depends on the main diagnosis, other diagnoses and the procedures carried out, so the final amount is known only after the stay.
Many German hospitals have cancer centres certified by the German Cancer Society (Deutsche Krebsgesellschaft), which must show every year that they meet tumour-specific requirements based on medical guidelines.
Top Hospitals in Germany
Recommended Hospitals for Lu177-PSMA Therapy
Frequently Asked Questions Related to Lu177-PSMA Therapy Cost in Germany
Lu-177 PSMA therapy is a radioactive medicine that targets prostate cancer cells carrying the PSMA protein. It delivers radiation directly to the cancer.
UCLH explains that it is used for metastatic prostate cancer that no longer responds to hormone therapy. A PSMA scan checks suitability.
It is given as a drip over about 30 minutes, according to UCLH. Up to six treatments are given 6 weeks apart.
UCLH advises a separate bed for 2 to 3 days, distance from children for 7 days and from pregnant partners for 15 days. These limit radiation exposure.
Dry mouth, tiredness and feeling sick are common. The bone marrow can be suppressed in 1 to 10 in 100 people.
Blood tests check the bone marrow, which can be suppressed by the treatment. Doses may be delayed if counts are low.
The cost of lu-177 PSMA therapy in Germany typically ranges from $2,500 to $22,000 USD, depending on the hospital, city, and type of procedure.
Up to six treatments are given 6 weeks apart, according to UCLH. The team reviews response along the way.
Yes, a PSMA PET scan checks whether the cancer carries enough PSMA for the treatment to work. It guides the decision.
Radionuclide therapy is offered in nuclear medicine departments, often within certified cancer centres. Ask whether the hospital treats prostate cancer regularly.














